tbuckley/cabot-search huggingface dataset:
Stage-specific embryonic antigen-4 as a novel marker of ductal cells of human eccrine sweat glands
Authors: J. Borowczyk-Michalowska, E. Zimolag, A. Waligorska, J. Dobrucki, Z. Madeja, J. Drukala
Journal: British Journal of Dermatology (2016)

Different populations of unipotent or multipotent stem cells have been identified in human epidermis and its appendages. It is well documented that these cells maintain tissue homeostasis and actively participate in epidermal regeneration after injury. However, there is no evidence of the presence of pluripotent stem cells in human epidermis.In this study we investigated whether cells positive for embryonic stem cell marker stage-specific embryonic antigen-4 (SSEA-4) are present in adult human epidermis and, if so, whether they are pluripotent and correspond to the population of primitive stem cells.The expressions of SSEA-4 and pluripotency transcription factors were analysed using flow cytometry. By means of immunohistochemical staining, we studied the exact localization of these cells in sections of human skin.We show that a population of SSEA-4+ cells is present in human epidermis. In contrast to the commonly accepted belief, the expression of SSEA-4 is not connected with the pluripotent character of isolated cells. We found that these SSEA-4+ cells are localized in the ducts of eccrine sweat glands.Our results indicate that SSEA-4 is a novel marker identifying the ductal cells of human sweat glands. The surface character of the antigen provides for a simple method of isolating this cell population and suggests applications of SSEA-4 for future cell therapy research.
Brentuximab Vedotin in Combination with RCHOP As Front-Line Therapy in Patients with DLBCL: Interim Results from a Phase 2 Study
Authors: Christopher A. Yasenchak, Charles M. Farber, Lihua Elizabeth Budde, Stephen M. Ansell, Ranjana Advani, Beata Holkova, Ahmad Halwani, Mark Knapp, Luis Fayad, Kathryn S. Kolibaba, Dipti Patel-Donnelly, Mahesh Seetharam, Thomas J. Manley, Nancy L. Bartlett
Journal: Blood (2014)
Harnessing the Immune System as a Therapeutic Tool in Virus-Associated Cancers
Authors: Rafael Santana-Davila, Shailender Bhatia, Laura Q. M. Chow
Journal: JAMA Oncology (2016)

There are at least 7 viruses implicated in the pathogenesis of 10% to 15% of all human cancers worldwide. Despite a high prevalence of infection with these viruses, only a minority of infected individuals develop a subsequent malignant tumor, underscoring the important role that host and environmental factors have in cancer development. This article reviews the mechanisms of viral carcinogenesis, with an emphasis on the viral evasion of the host immune system, and discusses how to harness the immune system effectively as a therapeutic tool in select cancers.Immune evasion mechanisms of these viral infections have an important role in carcinogenesis. Increased understanding of these mechanisms has paved the way for using immunotherapy to treat virus-associated cancers. This study summarizes the use of adoptive cell therapy, tumor vaccines, immune checkpoint inhibitors, and combination immunotherapies in the treatment of select virus-associated cancers.Immunotherapy is proving to be a useful strategy in the treatment of virus-associated cancers. A greater understanding of the processes of immune evasion in chronic infections and malignant tumors will continue to help in the goal of optimizing immunotherapy, which will in turn translate into remission and long-term survival in this patient population.
A Phase I Study of the HDAC Inhibitor LBH589 in Combination with Imatinib for Patients with CML in Cytogenetic Remission with Residual Disease Detectable by Q-PCR.
Authors: Ravi Bhatia, David S. Snyder, Allen Lin, Jennifer Arceo, Linda Seymour, Michael Deininger, Jerald Radich, Suzette Blanchard, Stephen Forman
Journal: Blood (2009)
Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
Authors: Charles Herbaux, Jordan Gauthier, Pauline Brice, Luc Fornecker, Krimo Bouabdallah, Guillaume Manson, Hervé Ghesquières, Anne Thiebaut-Bertrand, Hélène Demarquette, Eileen Boyle, Loic Ysebaert, Roch Houot, Ibrahim Yakoub-Agha, Franck Morschhauser
Journal: Blood (2015)
Bloodless Cancer Treatment Results of Patients Who Do Not Want Blood Transfusion: Single Center Experience of 77 Cases
Authors: Sung Hyun Kim, Sung Yong Oh, Hyuk-Chan Kwon, Suee Lee, Dong Mee Lee, Kyeong Hee Kim, Jin-Yeong Han, Joo- In Park, Jong-Hwan Lee, Kyu-Yeol Lee, Hyo-Jin Kim
Journal: Blood (2008)
A Phase I Study of the Aurora a Kinase Inhibitor Alisertib in Combination with 7+3 Induction Chemotherapy in Patients with Acute Myeloid Leukemia
Authors: Amir T. Fathi, Seth A. Wander, Traci M. Blonquist, Karen K. Ballen, Eyal C. Attar, Steven L. McAfee, Yi-Bin Chen, Timothy A. Graubert, Andrew M. Brunner, Christelle Joseph, Ashley M. Perry, Meghan Burke, Regina Silver, Aura Y. Ramos, Christine Connolly, Donna S. Neuberg, Philip C. Amrein
Journal: Blood (2014)
Doubts About Therapy for Neurological Diseases With Antisense Oligonucleotides—Reply
Authors: David R. Corey
Journal: JAMA Neurology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Neurology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Neurology journal
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Engraftment and Antitumor Responses Against Mantle Cell Lymphoma
Authors: Marco Ruella, Saad S Kenderian, Olga Shestova, Joseph A. Fraietta, Sohail Qayyum, Qian Zhang, Marcela V. Maus, Xiaobin Liu, Selene Nunez-Cruz, Michael Klichinsky, Omkar Uday Kawalekar, Michael C. Milone, Simon F. Lacey, Anthony Mato, Stephen J. Schuster, Michael Kalos, Carl H. June, Saar I Gill, Mariusz A. Wasik
Journal: Blood (2015)
Treatment Side Effects
Authors: Elisabeth Ortmann, Gerda Hohenberg
Journal: Journal of Clinical Oncology (2002)

Article Tools DIAGNOSIS IN ONCOLOGY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2002.20.13.3029 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 12089233 Treatment Side Effects Case 1. Radiation Recall Phenomenon After Administration of Capecitabine Elisabeth OrtmannxElisabeth OrtmannSearch for articles by this author , Gerda HohenbergxGerda HohenbergSearch for articles by this author Show More University of Vienna Medical School, Vienna, Austria https://doi.org/10.1200/JCO.2002.20.13.3029 First Page Full Text PDF Figures and Tables © 2002 by American Society of Clinical Oncology
BIOMECHANICAL DIFFERENCES BETWEEN CASES WITH CECS AND ASYMPTOMATIC CONTROLS DURING WALKING AND MARCHING
Authors: A Roberts, D Roscoe, D Hulse, A Bennett, S Dixon
Journal: British Journal of Sports Medicine (2016)

No primary research has been carried out to investigate the predisposing biomechanical and anthropometric factors for chronic exertional compartment syndrome. The aim of this study was to investigate the kinematic and kinetic differences in cases with chronic exertional compartment syndrome and controls. 20 males with symptoms of chronic exertional compartment syndrome of the anterior compartment and 20 male asymptomatic controls were studied. Anthropometry and three-dimensional kinematics and kinetics were compared during walking and marching. Bootstrapped t-tests were carried out on each individual normalised time point to identify regions within the gait cycle that were significantly different. Cases were shorter in stature and took a relatively longer stride in relation to leg length than controls. There were no differences in weight or height-to-leg length ratio. Kinematic differences were only identified at the ankle. Cases demonstrated increased ankle plantarflexion from mid-stance to toe-off. Cases also demonstrated less ankle inversion at the end of stance and early swing phases which coincided with the generation of lower ankle inversion moments. The anthropometric and biomechanical differences demonstrated provide a plausible mechanism for the development of chronic exertional compartment syndrome in this population. Shorter stature in combination with a relatively longer stride length may result in an increased demand on tibialis anterior during ambulation. The speed at which humans begin to transition to running is dependent on stature and is close to the marching speed in this study. Tibialis anterior is reported to be a key determinant of this speed. Many participants reported having previously experienced the urge to transition to a run in order to alleviate their pain. The results of this study, together with clinical insights and published research suggest that the suppression of the walk-to-run stimulus during military group marches may play a significant role in the development of chronic exertional compartment syndrome within a military population. The differences in joint angles and moments also indicate an impairment of the effectiveness of tibialis anterior. It is unclear whether this is a cause or consequence of chronic exertional compartment syndrome.
FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma
Authors: Masaya Okada, Yoshihiro Fujimori, Naohiko Oku, Akira Tamekane, Toshiro Takafuta, Toshiyuki Nakajima, Tazuko Tokugawa, Akihiro Sawada, Shin-ichi Ishii, Katsuji Kaida, Kazuhiro Ikegame, Toshihiro Soma, Hiroyasu Ogawa
Journal: Blood (2012)
Safe and Effective Treatment of Patients with Peripheral T-Cell Lymphoma (PTCL) with the Novel HDAC Inhibitor, Belinostat, in Combination with CHOP: Results of the Bel-CHOP Phase 1 Trial
Authors: Patrick B. Johnston, Amanda F. Cashen, Petros G. Nikolinakos, Anne W Beaven, Stefan Klaus Barta, Gajanan Bhat, Tao Song, Mi Rim Choi, Lee F. Allen, Sven de Vos, Yasuhiro Oki, Changchun Deng, Francine M Foss
Journal: Blood (2015)
Lenalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma; Dosing of Lenalidomide According to Renal Function and Effect On Renal Impairment.
Authors: Meletios A. Dimopoulos, Dimitrios Christoulas, Maria Roussou, Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, Maria Gkotzamanidou, Marina Iakovaki, Charis Matsouka, Despina Mparmparoussi, Erasmia Psimenou, Irini Grapsa, Eleni Efstathiou, Evangelos Terpos
Journal: Blood (2009)
Microarray-Based Method for Quantificationally Detecting Methylation Changes of E-Cadherin Gene in Acute Leukemia.
Authors: Bao-An Chen, Fan Zhang, Yan Wang, Chong Gao, Jia-Hua Ding, Yun Yu, Jian Cheng, Jun Wang, Gang Zhao, Zu-Hong Lu, Ning-Na Chen, Fei Fei
Journal: Blood (2006)
Surface functionalization of titanium implants with chitosan-catechol conjugate for suppression of ROS-induced cells damage and improvement of osteogenesis
Authors: Weizhen Chen, Xinkun Shen, Yan Hu, Kui Xu, Qichun Ran, Yonglin Yu, Liangliang Dai, Zhang Yuan, Ling Huang, Tingting Shen, Kaiyong Cai
Journal: Biomaterials (2016)
Abstract P2-12-15: Understanding the complex non face-to-face interventions delivered by the clinical nurse specialists in metastatic breast cancer.
Authors: M Warren, D Mackie, A Leary
Journal: Cancer Research (2012)

Abstract Introduction: Despite improving survival rates in breast cancer, globally one third of patients diagnosed with primary breast cancer will go onto develop metastatic breast cancer. In recent years treatment for metastatic breast cancer in the United Kingdom has moved to the ambulatory setting using treatments such as, oral chemotherapies, oral biological and bisphosphonate therapies meaning telephone consultation and clinical management, pivotal to confluent care. Research Objectives: To determine the number and complexity of incoming telephone calls, the stage of the metastatic breast cancer disease pathway for example at diagnosis, treatment, follow-up, and palliative care, the nursing interventions, outcomes and the reason for contact from patients and carers. Rationale: Previous studies demonstrate much of the clinical work of the clinical nurse specialist is delivered via the telephone. The rationale of this study was to examine the complexity of non face-to-face patient interaction with the metastatic breast cancer clinical nurse specialist. Method: A prospective study conducted over a 1 – month period at a United Kingdom National Health Service Foundation Hospital Trust. Data was collected by two clinical nurse specialists on incoming calls using Excel and a bespoke interrelational structured query database. These data were then mined using standard data mining techniques and pattern recognition techniques. Results: The study collected 28 days of data. 229 patient and carer telephone contacts were recorded. Most calls were from patients (62.5%). Incoming calls resulted in the delivery of 1282 interventions, a mean of six interventions per call (range1-8) and clustered into four areas: meeting information needs (29%), symptom management (26%), psychological/social issues (33%) and other issues (12%). The incoming telephone work accounted for 63 h which represented 30% of the total working time of the clinical nurse specialist. Calls primarily originated from patients who were in the follow-up phase (43% of calls), a group usually thought to prefer self management. Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P2-12-15.
Persistent Mixed Chimerism in Plasma Cells Following Allogeneic Stem-Cell Transplantation in Patients with Acute Leukemia Is a Surrogate Marker for Leukemia Relapse.
Authors: Avichai Shimoni, Trakhtenbrot Luba, Ishoev Galina, Izhar Hardan, Noga Shem-Tov, Gideon Rechavi, Ninette Amariglio, Arnon Nagler
Journal: Blood (2005)
No Significant Clinical Benefit of First Line Therapy with Fludarabine (F) in Comparison to Chlorambucil (Clb) in Elderly Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Phase III Study of the German CLL Study Group (GCLLSG).
Authors: Barbara F. Eichhorst, Raymonde Busch, Martina Stauch, Manuela Bergmann, Matthias Ritgen, Nicole Kranzhöfer, Carmen D. Schweighofer, Kirsten Fischer, Anna-Maria Fink, Paula Cramer, Valentin Goede, Clemens M. Wendtner, Michael Hallek
Journal: Blood (2007)
Array Comparative Genomic Hybridization: Impact in the Assessment of Plasma Cell Myeloma Genetic Profile and Prognosis
Authors: Annette Leon, Deborah Sevilla, Joseph M Marino, Kenneth D Moreno, Rev Obrera, Liliya Feldman, Yan G Fan, Rajendra Persad, Cesar Villamil, Melissa Maya, Nirav Mehta, Denise O'Dea, Yelena Kemel, Amitabha Mazumder, James Weisberger
Journal: Blood (2012)
Anti-Sclerostin Treatment Prevents Multiple Myeloma Induced Bone Loss and Reduces Tumor Burden
Authors: Michaela R. Reagan, Michelle McDonald, Rachael Terry, Jessica Pettitt, Lawrence Le, Sindhu Mohanty, Michaela Kneissel, Ina Kramer, Daniel Brooks, Mary Bouxsein, Clifford J. Rosen, Irene M. Ghobrial, Peter Croucher
Journal: Blood (2015)
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors
Authors: Emilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, Michael Fraser, Syed Haider, Alice Meng, Junyan Zheng, Cindy Q. Yao, Valerie Picard, Michele Orain, Helène Hovington, Jure Murgic, Alejandro Berlin, Louis Lacombe, Alain Bergeron, Yves Fradet, Bernard Têtu, Johan Lindberg, Lars Egevad, Henrik Grönberg, Helen Ross-Adams, Alastair D. Lamb, Silvia Halim, Mark J. Dunning, David E. Neal, Melania Pintilie, Theodorus van der Kwast, Robert G. Bristow, Paul C. Boutros
Journal: European Urology (2016)
Assessment of Plasma Prothrombotic Factors in Patients with Buerger’s Disease.
Authors: Iwona Hus, Bozena Sokolowska, Marek Chrapko, Aleksandra Nowaczynska, Adam Walter-Croneck, Kamila Mazurek, Magdalena Lewandowska, Jacek M. Rolinski, Anna Dmoszynska
Journal: Blood (2008)
ADDUCTOR LONGUS ACTIVATION DURING TWO COMMON HIP ADDUCTION EXERCISES
Authors: C Long, N Light
Journal: British Journal of Sports Medicine (2016)

Various exercises are prescribed in the management of adductor-related groin pain. Isometric adductor ball squeeze exercises are commonly incorporated into both prevention and rehabilitation training, as is the Copenhagen Adduction exercise, which offers a more dynamic and challenging alternative. The adductor longus (AL) muscle is commonly indicated in adductor pathology and may be considered a ‘target’ tissue, yet there is minimal literature examining adductor muscle activation during such exercises. Understanding variation in levels of AL activation during differing exercises, may inform exercise selection. Nine healthy university football players completed a number of repetitions of adductor ball squeezes (45° hip flexion) and Copenhagen adductions, with surface electromyography (sEMG) measuring their AL activity. Results showed that isometric ball squeezes produced larger average AL activity than the Copenhagen adduction exercise (p&lt;0.046). The ball squeeze exercise also demonstrated higher percentage of peak sEMG activity (33%) compared to the Copenhagen adduction exercise (26%). No statistically significant differences between peak sEMG values were observed. The results suggest that AL activation is higher during an isometric ball squeeze when compared with the Copenhagen adduction exercise, despite being a more dynamic and stressful exercise. This may be related to altered synergistic muscle recruitment and varying working muscle lengths, which have been shown to alter EMG activity levels. Adductor ball squeezes are safe, load adjustable and simple to instruct requiring no assistance. Subsequently, they remain ideally suited in various contexts, for example pre-activation exercises prior to activity (prevention) and during early phase loading post adductor related injury (treatment), where the Copenhagen adduction exercise is not indicated.
Poster Symposia 443–498
Authors: Brun Buisson, Kauczor Hu, Y Koh, Chen Xiao-Li, Lin Jian-Dong, Liu Ning, E Fernandez-Mondejar, J Castsaeo-Pørez, M Colmenero-Ruiz, M Rivera-Fernandez, Perez-Villares Jm, Rodriguez-Elvira Servicio, Cuidados Criticos, Meyanci Koksal
Journal: Intensive Care Medicine (2001)
The Total Amount of Kappa Plus Lambda Serum Immunoglobulin Free Light Chains (sFLC κ+λ) Is a Powerful Independent Predictor of Time to First Treatment In Chronic Lymphocytic Leukemia (CLL) and Allows Definition of a Novel Prognostic Scoring System: A Study of 449 Therapy-naïve Patients
Authors: Fortunato Morabito, Rosaria De Filippi, Luca Laurenti, Katja Zirlik, Anna Grazia Recchia, Massimo Gentile, Emanuela Morelli, Solluzzo Cavalcanti, Giancarla Iaccarino, Barbara Amoroso, Antonino Neri, Giovanna Cutrona, Manlio Ferrarini, Stefano Molica, Giovanni Del Poeta, Antonio Pinto
Journal: Blood (2010)
The Modulation of Fluorouracil With Leucovorin in Metastatic Colorectal Carcinoma
Authors: Nicholas Petrelli, Harold O. Douglass, Lemuel Herrera, David Russell, Donald M. Stablein, Howard W. Bruckner, Robert J. Mayer, Roger Schinella, Michael D. Green, Franco M. Muggia, Alec Megibow, Edward S. Greenwald, Ronald M. Bukowski, Jules Harris, Bernard Levin, Ellen Gaynor, Antoine Loutfi, Martin H. Kalser, Jamie S. Barkin, Pasquale Benedetto, Paul V. Woolley, Russell Nauta, Donald W. Weaver
Journal: Journal of Clinical Oncology (1990)

The authorship of the report "The Modulation of Fluorouracil With Leucovorin in Metastatic Colorectal Carcinoma: A Randomized Phase III Trial," published in the October 1989 issue (J Clin Oncol 7:1419–1426, 1989) should have read: "by the Gastrointestinal Tumor Study Group." The following appendix should also have appeared at the end of the report:
Self-Peptide Recognition of Posterior Eye Segment Epitopes Mediated By Allogeneic T Cells in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Authors: Nora Mirza, Manfred Zierhut, Andreas Korn, Antje Bornemann, Christoph Simon, Annika Boehm, Wolfgang A. Bethge, Lothar Kanz, Hans-Georg Rammensee, Sebastian P. Haen
Journal: Blood (2014)
Bone Marrow Mesenchymal Stromal Cells Protect Acute Lymphocytic Leukemia Cells From Cytotoxic Agents Via MAPK/Erk and Wnt/β-Catenin Signal Pathways
Authors: Kaimin Hu, Lizhen Liu, Binsheng Wang, Kangni Wu, Shan Fu, Yanjun Gu, Xiaoyu Lai, Xiaohong Yu, He Huang
Journal: Blood (2012)
Soluble Bcma in Myeloma Serum Binds Its Ligands BAFF and Prevents Normal Antibody Production in Multiple Myeloma Patients
Authors: Eric Sanchez, Abigail Gillespie, Nika Manik Harutyunyan, George Tang, Jillian Gottlieb, Suzie Vardanyan, Mingjie Li, Claudia Andreu-Vieyra, Michael Ghermezi, Cathy Wang, Joseph Ben-Zvi, Gigi Garzio, Haiming Chen, James Berenson
Journal: Blood (2015)
Delayed Severe Neutropenia after Rituximab Therapy in 18 among 293 Patients with B-Cell Malignancies Treated in a Single Institution. an Adverse Event of Unknown Mechanism.
Authors: Karim Belhadj, Taoufik El Gnaoui, Kamal Doghmi, Bertrand Joly, Ketty Lee, Anne Plonquet, Hélène Jouault, Karine Gourlain, Marie-Hélène Delfau-Larue, Chantal André, Felix Reyes, Corinne Haioun
Journal: Blood (2004)
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study
Authors: Mark D. Tyson, JoAnn Alvarez, Tatsuki Koyama, Karen E. Hoffman, Matthew J. Resnick, Xiao-Cheng Wu, Matthew R. Cooperberg, Michael Goodman, Sheldon Greenfield, Ann S. Hamilton, Mia Hashibe, Lisa E. Paddock, Antoinette Stroup, Vivien W. Chen, David F. Penson, Daniel A. Barocas
Journal: European Urology (2016)
PPAR-γ Agonists Induce Growth Arrest of Kit/AML1-ETO Leukemia Cells Acting on Diverse Pathways
Authors: Valter Agosti, Daniela Talarico, Agostina Urzino, Raghavendra Vasudeva Murthi, Aurora Anna Rita Nocera, Emilia Dora Giovannone
Journal: Blood (2014)
Autologous Stem Cell Transplantation (auto-SCT) in Elderly Patients with Multiple Myeloma (MM): Age per se Does Not Affect Outcome.
Authors: Jean El-Cheikh, Elias Kfoury, Christian Chabannon, Anne-Marie Stoppa, Reda Bouabdallah, Diane Coso, Jean-Marc Schiano de Collela, Vadim Ivanov, Therese Aurran, Jean-Albert Gastaut, Didier Blaise, Mohamad Mohty
Journal: Blood (2007)